Position
Fidelity in Maze Therapeutics, Inc.
Back to the book · All holders of MAZE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$8.65K$29.85 → $29.84
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 728.6K | $30.2M | — | — | — | 0.0% |
| Q1 2026 | 864.2K | $25.8M | $29.85 | −$8.44M | $4.05M | 0.0% |
| Q2 2026 | 1.06M | $31.5M | $29.84 | −$8.65K | $5.75M | 0.0% |